Quetiapine hemifumarate salt, >=98% (HPLC)

Quetiapine hemifumarate salt, >=98% (HPLC)

Application

Quetiapine hemifumarate salt has been used as an antagonist for ?-arrestin 2 mutant T205M recruitment.

Biochem/physiol Actions

Quetiapine hemifumarate is an atypical antipsychotic, a combined serotonin (5HT2) and dopamine (D2) receptor antagonist.

Quetiapine promotes oligodendrogenesis in vitro. It is used in treating depressive disorders.

Features and Benefits

This compound was developed by AstraZeneca. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

This compound is featured on the Dopamine Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

General description

Quetiapine is a derivative of dibenzothiazepine compound and is also referred to as seroquel and clemastine.

Packaging

10, 50 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level InChI key InChI Manufacturer Form Assay Price Quantity
3573873 Quetiapine hemifumarate salt, >=98% (HPLC) white to off-white 100 ZTHJULTYCAQOIJ-WXXKFALUSA-N 1S/2C21H25N3O2S.C4H4O4/c2*25-14-16-26-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)27-20-8-4-2-6-18(20)22-21;5-3(6)1-2-4(7)8/h2*1-8,25H,9-16H2;1-2H,(H,5,6)(H, SIGMA-ALDRICH powder ≥98% (HPLC)
£134.83 (exc VAT) per 10MG
-
+
3573874 Quetiapine hemifumarate salt, >=98% (HPLC) white to off-white 100 ZTHJULTYCAQOIJ-WXXKFALUSA-N 1S/2C21H25N3O2S.C4H4O4/c2*25-14-16-26-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)27-20-8-4-2-6-18(20)22-21;5-3(6)1-2-4(7)8/h2*1-8,25H,9-16H2;1-2H,(H,5,6)(H, SIGMA-ALDRICH powder ≥98% (HPLC)
£490.29 (exc VAT) per 50MG
-
+